Biocentis

Operator of a genetic control technology designed to target harmful insect species that transmit diseases, destroy crops, and threaten biodiversity. The company offers innovative, precision-driven gen...

Healthcare

London, United Kingdom

Founded 2022

16 employees

Website

Valuation

Share Price

N/A

Total Raised

$13.9M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Biocentis's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required